Suppr超能文献

累及颞骨的皮肤鳞状细胞癌的淋巴结转移模式。

Pattern of nodal metastasis of cutaneous squamous cell carcinoma involving the temporal bone.

作者信息

Hintze Justin M, O'Riordan Isobel, Jones Holly, McHugh Alison, Gendre Adrien, Timon Conrad, Kinsella John, Lennon Paul, Walsh Rory McConn, Shine Neville, O'Neill James P

机构信息

Department of Otolaryngology-Head and Neck Surgery Beaumont Hospital Dublin Ireland.

Royal College of Surgeons in Ireland Dublin Ireland.

出版信息

Laryngoscope Investig Otolaryngol. 2022 Dec 16;8(1):120-124. doi: 10.1002/lio2.981. eCollection 2023 Feb.

Abstract

OBJECTIVE

The objective of this study was to explore the pattern of lymph-node spread of SCCs involving the temporal bone.

METHODS

We retrospectively reviewed all cutaneous SCCs involving the temporal bone over a 20-year time-period. Forty-one patients were eligible.

RESULTS

Mean age was 72.8 years. The diagnosis was cutaneous SCC in all cases.All patients underwent a temporal bone resection, 70.7% had a neck-dissection and 78.0% a parotidectomy.Level 2 was the most common area of neck metastasis, and occurred in 12.2%. The parotid had disease in 34.1%. 51.2% of patients underwent free-flap reconstruction.Mean overall survival of the cohort was 4.2 years.

CONCLUSIONS

Overall, the rate of cervical nodal metastasis was 22.0% and 13.5% in the occult setting. The parotid was involved in 34.1% and 10.0% in the occult setting. Results from the present study support consideration for performing a parotidectomy at the time of temporal bone resection, while a neck dissection can be performed for adequate staging of the nodal basin.

LEVEL OF EVIDENCE

摘要

目的

本研究的目的是探讨累及颞骨的鳞状细胞癌的淋巴结转移模式。

方法

我们回顾性分析了20年间所有累及颞骨的皮肤鳞状细胞癌。41例患者符合条件。

结果

平均年龄为72.8岁。所有病例诊断均为皮肤鳞状细胞癌。所有患者均接受了颞骨切除术,70.7%的患者进行了颈部清扫术,78.0%的患者进行了腮腺切除术。2区是颈部转移最常见的部位,发生率为12.2%。腮腺受累率为34.1%。51.2%的患者接受了游离皮瓣重建。该队列的平均总生存期为4.2年。

结论

总体而言,隐匿性情况下颈部淋巴结转移率为22.0%,腮腺受累率在隐匿性情况下为34.1%和10.0%。本研究结果支持在颞骨切除时考虑进行腮腺切除术,而颈部清扫术可用于对淋巴结区域进行充分分期。

证据等级

3级。

相似文献

1
Pattern of nodal metastasis of cutaneous squamous cell carcinoma involving the temporal bone.
Laryngoscope Investig Otolaryngol. 2022 Dec 16;8(1):120-124. doi: 10.1002/lio2.981. eCollection 2023 Feb.
2
The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
JAMA Otolaryngol Head Neck Surg. 2014 Jun;140(6):548-54. doi: 10.1001/jamaoto.2014.352.
3
Elective parotidectomy and neck dissection are not beneficial in cutaneous squamous cell carcinoma of the head.
Braz J Otorhinolaryngol. 2024 Jan-Feb;90(1):101352. doi: 10.1016/j.bjorl.2023.101352. Epub 2023 Oct 23.
4
The role of total parotidectomy in high-grade parotid malignancy: A multisurgeon retrospective review.
Am J Otolaryngol. 2022 Jan-Feb;43(1):103194. doi: 10.1016/j.amjoto.2021.103194. Epub 2021 Sep 2.
5
Parotidectomy and neck dissection in locally advanced and relapsed cutaneous squamous cell carcinoma of the head and neck region.
Braz J Otorhinolaryngol. 2022 Nov-Dec;88 Suppl 4(Suppl 4):S152-S162. doi: 10.1016/j.bjorl.2021.11.007. Epub 2021 Dec 10.
7
8
Metastatic cutaneous squamous cell carcinoma to the parotid and cervical lymph nodes: treatment and outcomes.
Curr Opin Otolaryngol Head Neck Surg. 2009 Apr;17(2):122-5. doi: 10.1097/MOO.0b013e32832924e0.
9
Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
J Plast Reconstr Aesthet Surg. 2006;59(12):1288-93. doi: 10.1016/j.bjps.2006.03.043. Epub 2006 Jun 5.
10

本文引用的文献

1
Locally advanced non-melanomatous skin cancer: Contemporary radiotherapeutic management.
Oral Oncol. 2019 Dec;99:104443. doi: 10.1016/j.oraloncology.2019.104443. Epub 2019 Nov 22.
2
Management of Parotid Metastatic Cutaneous Squamous Cell Carcinoma: Regional Recurrence Rates and Survival.
Otolaryngol Head Neck Surg. 2018 Aug;159(2):293-299. doi: 10.1177/0194599818764348. Epub 2018 Mar 13.
3
Update on Surgical Outcomes of Lateral Temporal Bone Resection for Ear and Temporal Bone Malignancies.
J Neurol Surg B Skull Base. 2017 Feb;78(1):37-42. doi: 10.1055/s-0036-1584310. Epub 2016 Jun 10.
4
The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
JAMA Otolaryngol Head Neck Surg. 2014 Jun;140(6):548-54. doi: 10.1001/jamaoto.2014.352.
5
Deep lobe parotidectomy: clinical rationale in the management of primary and metastatic cancer.
Eur Arch Otorhinolaryngol. 2014 May;271(5):1181-5. doi: 10.1007/s00405-013-2616-8. Epub 2013 Jul 6.
6
Guidelines for treating temporal bone carcinoma based on long-term outcomes.
Otol Neurotol. 2013 Jul;34(5):898-907. doi: 10.1097/MAO.0b013e318281e0a9.
7
Predictors of survival and recurrence after temporal bone resection for cancer.
Head Neck. 2012 Sep;34(9):1231-9. doi: 10.1002/hed.21883. Epub 2011 Sep 23.
8
Pathologic occult neck disease in patients with metastatic cutaneous squamous cell carcinoma to the parotid.
Otolaryngol Head Neck Surg. 2011 Apr;144(4):549-51. doi: 10.1177/0194599810395361. Epub 2011 Feb 3.
9
Survival outcomes in surgical treatment of 72 cases of squamous cell carcinoma of the temporal bone.
Otol Neurotol. 2011 Jun;32(4):665-9. doi: 10.1097/MAO.0b013e318210b90f.
10
Parotid and temporal bone resection for skull base malignancies: outcome.
Skull Base. 2010 May;20(3):169-77. doi: 10.1055/s-0030-1247634.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验